As cell and gene therapies continue to progress at a rapid pace, apheresis and collection centers face the challenges of keeping up with demand, while maintaining high-quality levels.
View this on-demand webinar for an in-depth discussion of standardization strategies that can bring efficiencies to the apheresis and collection infrastructure. Also included is a Q&A session between live webinar attendees and the following experts:
- Amy Hines, director of collection network management, NMDP BioTherapies (formerly Be The Match BioTherapies)
- Heather Steinmetz, MPH, quality assurance manager, UCLA Health
- Greg Whitehead, vice president of quality, bluebird bio